Phase 1 β Early testing in a small group of people (usually 20β80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(27 sites)
United States
Research Site, Tampa, Florida Research Site, Louisville, Kentucky Research Site, New Brunswick, New Jersey Research Site, Charlotte, North Carolina Research Site, Columbus, Ohio